The city of Amarillo, Texas, currently has 3 active clinical trials seeking participants for Diabetes research studies.
A Phase III Study to Investigate If the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed with Type 1 Diabetes
Recruiting
The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd compared to placebo, along with oral Vitamin D supplementation, to preserve endogenous beta cell function and influence glycemic parameters in adolescent and adults recently diagnosed with T1D carrying the HLA DR3-DQ2 haplotype.
Gender:
ALL
Ages:
Between 12 years and 28 years
Trial Updated:
02/19/2025
Locations: Amarillo Medical Specialists, Amarillo, Texas
Conditions: Type 1 Diabetes Mellitus
Transform: Teaching, Technology, and Teams
Recruiting
This initiative supports a quality improvement effort evaluating the use of strategies (including technology-based decision support, referral to a virtual GDMT team, and general educational tools/resources for clinicians and patients) to improve use of guideline-directed therapeutics known to lower cardiovascular (CV) events among patients with cardiovascular diseases of heart failure, atrial fibrillation and type 2 diabetes (T2D)/ASCVD with a specific focus on underserved populations and those... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
10/05/2022
Locations: Cardiology Center of Amarillo, Amarillo, Texas
Conditions: Heart Failure, Type 2 Diabetes, Atrial Fibrillation
Continuous Monitoring and Control of Hypoglycemia
Recruiting
Evaluate safety of non-adjunctive CGM use in CGM naive participants.
Gender:
All
Ages:
2 years and above
Trial Updated:
09/17/2021
Locations: Amarillo Medical Specialists, LLP, Amarillo, Texas
Conditions: Diabetes